Organon & Co.

NYSE:OGN Stock Report

Market Cap: US$4.7b

Organon Future Growth

Future criteria checks 2/6

Organon is forecast to grow earnings and revenue by 7.2% and 0.2% per annum respectively. EPS is expected to grow by 6.8% per annum. Return on equity is forecast to be 97.7% in 3 years.

Key information

7.2%

Earnings growth rate

6.8%

EPS growth rate

Pharmaceuticals earnings growth23.8%
Revenue growth rate0.2%
Future return on equity97.7%
Analyst coverage

Good

Last updated18 Sep 2024

Recent future growth updates

Recent updates

Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis

Sep 19

These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Sep 13
These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Organon & Co.: Cheap With Caveats

Aug 22

Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Aug 09
Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Aug 07
Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Jul 30

Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

May 29
Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

May 10
Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

Four Reasons Why Organon Stock Is A Good Buy

May 07

Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Apr 21
Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Organon Stock Is Still Worth A Look

Feb 24

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Feb 19
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last

Feb 16

Organon: What I'm Looking For In This 8% Yield In 2024

Jan 03

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

Dec 19

Organon: It's Darkest Before The Dawn

Nov 30

Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace

Nov 07

Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Nov 05
Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Organon: The Federal Reserve Black Swan (Rating Upgrade)

Oct 04

6% Yield And Significantly Undervalued: A Closer Look At Organon

Sep 10

Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk

Aug 10

Organon & Co.: A Tough Spot To Be In Right Now

Jul 16

Organon goes ex-dividend tomorrow

Feb 23

Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 19
Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Is There Anything Organic Or Interesting About Organon?

Feb 07

Organon goes ex-dividend tomorrow

Nov 09

Organon's (NYSE:OGN) Dividend Will Be $0.28

Nov 08
Organon's (NYSE:OGN) Dividend Will Be $0.28

Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Nov 05
Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Organon: Thoughts Ahead Of Q3 Earnings

Oct 31

Organon: What Is The Recipe?

Aug 31

Oragenics announces early toxicology data for intranasal COVID-19 vaccine

Aug 24

Organon, Samsung Bioepis Humira biosimilar Hadlima high concentration dosage gets FDA nod

Aug 17

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Aug 07
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Earnings and Revenue Growth Forecasts

NYSE:OGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,5091,0801,1101,1386
12/31/20256,4709791,0551,1097
12/31/20246,3937586581,1627
6/30/20246,3461,0007871,066N/A
3/31/20246,3471,047458761N/A
12/31/20236,2631,023538799N/A
9/30/20236,150585424669N/A
6/30/20236,168754320725N/A
3/31/20236,145746431849N/A
12/31/20226,174917431858N/A
9/30/20226,2921,011138638N/A
6/30/20226,3551,107343689N/A
3/31/20226,3651,3045641,077N/A
12/31/20216,3041,3511,9702,458N/A
9/30/20216,3141,5252,3702,841N/A
6/30/20216,3271,7622,3042,761N/A
3/31/20216,2581,9172,7723,025N/A
12/31/20206,5322,2561,9322,187N/A
12/31/20197,7773,3062,6752,767N/A
12/31/20189,7772,1533,5863,687N/A
12/31/201710,5001,801N/A3,419N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OGN's forecast earnings growth (7.2% per year) is above the savings rate (2.5%).

Earnings vs Market: OGN's earnings (7.2% per year) are forecast to grow slower than the US market (15.2% per year).

High Growth Earnings: OGN's earnings are forecast to grow, but not significantly.

Revenue vs Market: OGN's revenue (0.2% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: OGN's revenue (0.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: OGN's Return on Equity is forecast to be very high in 3 years time (97.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y